SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Drinking Colas Boost Cancer Risk? - University of California, Davis (UCD) Study
February 17, 2011
 · 
1 min read
Drug Development
People at Risk of Diabetes Offer Clues Toward Novel Drugs, Joslin Diabetes Center Study
February 15, 2011
 · 
1 min read
Drug Development
Estrogen Reduces Aggression in Breast Cancer, CIC bioGUNE Study Finds
February 14, 2011
 · 
1 min read
Drug Development
Offspring of Female Rats Given Folic Acid Supplements Develop More Breast Cancer, St. Michael’s Hospital Study Finds
February 14, 2011
 · 
1 min read
Drug Development
Mouse Study Suggests New Clues to Celiac Disease, University of Chicago Study
February 10, 2011
 · 
1 min read
Drug Development
Device Treatment May Silence Ringing in the Ears, University of Texas Reveals
January 13, 2011
 · 
1 min read
Drug Development
New Multiple Sclerosis Target Identified, University of Calgary Study
January 12, 2011
 · 
1 min read
Drug Development
AIDS Gel Prevents Infection in Monkeys, Population Council Study
January 6, 2011
 · 
1 min read
Drug Development
A Drug’s Likelihood Of Causing Birth Defects Predicted By Model, Children’s Hospital Boston Study
January 6, 2011
 · 
1 min read
Drug Development
Anti-Cocaine Vaccine Shows Promise in Mice, Weill Cornell Medical College Study Finds
January 5, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
May 6, 2026
 · 
6 min read
Press Releases
City Therapeutics Presents Preclinical Data on Next-Generation Investigational RNAi Therapy CITY-RBP4 for Treatment of Stargardt Disease at ARVO 2026 Annual Meeting
May 6, 2026
 · 
2 min read
Press Releases
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
May 6, 2026
 · 
4 min read
Press Releases
Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026
May 5, 2026
 · 
5 min read
Press Releases
Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week® 2026
May 5, 2026
 · 
6 min read
Press Releases
Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week
May 5, 2026
 · 
7 min read
Press Releases
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
May 4, 2026
 · 
6 min read
Press Releases
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
May 4, 2026
 · 
2 min read
Press Releases
Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting
May 4, 2026
 · 
2 min read
Press Releases
Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD
May 4, 2026
 · 
3 min read
Press Releases
Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease
May 4, 2026
 · 
7 min read
Press Releases
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
May 4, 2026
 · 
5 min read
Press Releases
Alcresta Therapeutics Announces Preclinical Data Evaluating RELiZORBneo Cartridge Use in Neonatal Murine Model of Necrotizing Enterocolitis
May 1, 2026
 · 
4 min read
Press Releases
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
April 30, 2026
 · 
6 min read
Press Releases
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
April 29, 2026
 · 
4 min read
Press Releases
Genexine’s First-in-Class SOX2 Degrader GX-BP1 Demonstrates Up to 96% TGI and Eliminates Tumor Regrowth in Preclinical Models
April 29, 2026
 · 
3 min read
Press Releases
Affinia Therapeutics to Present AFTX-201 for BAG3-Associated Dilated Cardiomyopathy (DCM) and Highlight Proprietary Capsid Engineering and Manufacturing Data at the American Society of Gene & Cell Therapy 2026 Annual Meeting
April 28, 2026
 · 
7 min read
Press Releases
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
April 28, 2026
 · 
8 min read
Press Releases
AIRNA to Present New Preclinical Data on RNA-Editing Therapeutic Pipeline at ASGCT Annual Meeting
April 28, 2026
 · 
3 min read
Press Releases
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
April 28, 2026
 · 
8 min read
Load More